[Study on epidemiological effect of the freeze-dried attenuated live varicella vaccine].
To evaluate the safety and epidemiological effect of the Freeze-dried Live attenuated varicella vaccine. A random, double-blind control clinical trial was adopted. In the observation period, the incidence of varicella was 0.8 per thousand in the experimental group and 8.7 per thousand in control group. There was a significant difference (B.P=0.000017). Vaccine effectiveness (VE(%)) was 90.8%, the lower limit of 95%CI was 88.7%. The varicella vaccine produced by Changchun keygen biological products co., Ltd. was safe and effective.